세계의 동물 장내 건강 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2033년)

Global Animal Intestinal Health Market size is anticipated to grow from USD 4.34 Billion in 2024 to USD 8.01 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.06% during the forecast period of 2026 to 2033.

The animal intestinal health market is poised for significant growth, driven by the increasing awareness of the importance of gut health in livestock and companion animals. As the global demand for animal protein rises, producers are increasingly focusing on optimizing animal health and performance to ensure sustainable production. The role of gut health in enhancing nutrient absorption, improving immunity, and reducing disease susceptibility is becoming more recognized, leading to a surge in demand for products that promote intestinal health.

Innovations in probiotics, prebiotics, and other gut health supplements are at the forefront of this market expansion. These products not only support digestive health but also contribute to overall animal well-being, which is critical in a competitive agricultural landscape. The growing trend towards natural and organic farming practices is further driving the demand for gut health solutions that align with these principles, as producers seek to minimize the use of antibiotics and other synthetic additives.

Moreover, the increasing incidence of zoonotic diseases and the rising consumer demand for safe, high-quality animal products are compelling producers to invest in animal health solutions. Regulatory pressures and the need for compliance with food safety standards are also significant factors driving the market. As research continues to unveil the intricate relationship between gut health and overall animal performance, the animal intestinal health market is expected to witness robust growth, with a focus on innovative solutions that cater to the specific needs of different animal species.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

• Probiotics
• Prebiotics
• Phytogenics
• Enzymes
• Organic Acids
• Others

By Animal Type

• Poultry
• Swine
• Ruminants
• Aquaculture
• Pets
• Others

By Form

• Dry
• Liquid

By Distribution Channel

• Veterinary Clinics
• Retail Stores
• Online Stores
• Others
• COMPANIES PROFILED
• Chr. Hansen Holding A/S
• Koninklijke DSM N.V.
• DuPont de Nemours Inc.
• Novozymes A/S
• Evonik Industries AG
• BASF SE
• Kemin Industries Inc.
• Cargill Incorporated
• Archer Daniels Midland Company
• Bluestar Adisseo Company
• Nutreco N.V.
• Alltech Inc.
• Novus International Inc.
• Biomin Holding GmbH
• Lallemand Inc.
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. ANIMAL INTESTINAL HEALTH a€" INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Animal Type
  • 3.7.3 Market Attractiveness Analysis By Form
  • 3.7.4 Market Attractiveness Analysis By Distribution Channel
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANIMAL INTESTINAL HEALTH MARKET ANALYSIS BY PRODUCT TYPE

• 5.1. Overview By Product Type
• 5.2. Historical and Forecast Data Analysis By Product Type
• 5.3. Probiotics Historic and Forecast Sales By Regions
• 5.4. Prebiotics Historic and Forecast Sales By Regions
• 5.5. Phytogenics Historic and Forecast Sales By Regions
• 5.6. Enzymes Historic and Forecast Sales By Regions
• 5.7. Organic Acids Historic and Forecast Sales By Regions
• 5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL ANIMAL INTESTINAL HEALTH MARKET ANALYSIS BY ANIMAL TYPE

• 6.1. Overview By Animal Type
• 6.2. Historical and Forecast Data Analysis By Animal Type
• 6.3. Poultry Historic and Forecast Sales By Regions
• 6.4. Swine Historic and Forecast Sales By Regions
• 6.5. Ruminants Historic and Forecast Sales By Regions
• 6.6. Aquaculture Historic and Forecast Sales By Regions
• 6.7. Pets Historic and Forecast Sales By Regions
• 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL ANIMAL INTESTINAL HEALTH MARKET ANALYSIS BY FORM

• 7.1. Overview By Form
• 7.2. Historical and Forecast Data Analysis By Form
• 7.3. Dry Historic and Forecast Sales By Regions
• 7.4. Liquid Historic and Forecast Sales By Regions

8. GLOBAL ANIMAL INTESTINAL HEALTH MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 8.1. Overview By Distribution Channel
• 8.2. Historical and Forecast Data Analysis By Distribution Channel
• 8.3. Veterinary Clinics Historic and Forecast Sales By Regions
• 8.4. Retail Stores Historic and Forecast Sales By Regions
• 8.5. Online Stores Historic and Forecast Sales By Regions
• 8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL ANIMAL INTESTINAL HEALTH MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
    
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ANIMAL INTESTINAL HEALTH COMPANIES

• 10.1. Animal Intestinal Health Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF ANIMAL INTESTINAL HEALTH INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Chr. Hansen Holding A/S
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Koninklijke DSM N.V.
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. DuPont De Nemours Inc.
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Novozymes A/S
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Evonik Industries AG
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. BASF SE
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Kemin Industries Inc.
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Cargill Incorporated
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Archer Daniels Midland Company
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Bluestar Adisseo Company
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments
• 11.13. Nutreco N.V.
  • 11.13.1 Company Overview
  • 11.13.2 Company Revenue
  • 11.13.3 Products
  • 11.13.4 Recent Developments
• 11.14. Alltech Inc.
  • 11.14.1 Company Overview
  • 11.14.2 Company Revenue
  • 11.14.3 Products
  • 11.14.4 Recent Developments
• 11.15. Novus International Inc.
  • 11.15.1 Company Overview
  • 11.15.2 Company Revenue
  • 11.15.3 Products
  • 11.15.4 Recent Developments
• 11.16. Biomin Holding GmbH
  • 11.16.1 Company Overview
  • 11.16.2 Company Revenue
  • 11.16.3 Products
  • 11.16.4 Recent Developments
• 11.17. Lallemand Inc
  • 11.17.1 Company Overview
  • 11.17.2 Company Revenue
  • 11.17.3 Products
  • 11.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies